Skip to main content
Year archive

OLIPASS CORPORATION — 2021 filings

All 75 regulatory filings released by OLIPASS CORPORATION (244460) in 2021, sourced directly from the official regulator.

75 Filings
2021 Period
2021 filings (75)
Filing Released Lang
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-12-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-12-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-12-24 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제9회차)
Capital/Financing Update
2021-12-20 Korean
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-16 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-12-16 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-12-16 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-12-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-12-02 Korean
주주총회소집공고
AGM Information
2021-11-26 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-11-26 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-12 Korean
주주총회소집결의
AGM Information
2021-10-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-10-28 Korean
기타경영사항(특허권취득)(자율공시)(티로시나제 안티센스 올리고뉴클레오타이드)
Regulatory Filings
2021-10-26 Korean
투자판단관련주요경영사항(비마약성진통제(OLP-1002) 호주 임상 2a상 시험 계획 승인)
Regulatory Filings
2021-10-13 Korean
기타경영사항(특허권취득)(자율공시)(SCN9A Antisense Pain Killer)
Regulatory Filings
2021-09-30 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-09-28 Korean
기타경영사항(특허권취득)(자율공시)(아세틸코에이카복실라제2 안티센스 올리고뉴클레오티드)
Regulatory Filings
2021-09-15 Korean
기타경영사항(특허권취득)(자율공시)(Exon Skipping by Peptide Nucleic Acid Derivatives)
Regulatory Filings
2021-09-02 Korean
투자판단관련주요경영사항(비마약성진통제(OLP-1002) 호주 임상 2a상 시험 계획 신청)
Legal Proceedings Report
2021-08-25 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
투자판단관련주요경영사항(OLP-1002 비마약성진통제 신약 호주 임상1B상 임상시험 종료)
Legal Proceedings Report
2021-07-30 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2021-07-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-06-22 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-06-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-15 Korean
[기재정정]기타경영사항(특허권취득)(자율공시)(SCN9A Antisense Pain Killer)
Regulatory Filings
2021-06-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-05-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-05-31 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-17 Korean
기타경영사항(특허권취득)(자율공시)(SCN9A Antisense Pain Killer)
Regulatory Filings
2021-05-07 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-05-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-04-06 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-04-06 Korean
기타경영사항(특허권취득)(자율공시)(TYROSINASE ANTISENSE OLIGONUCLEOTIDES)
Regulatory Filings
2021-04-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-02 Korean
기타경영사항(특허권취득)(자율공시)(티로시나아제 안티센스 올리고뉴클레오티드)
Regulatory Filings
2021-03-31 Korean
투자판단관련주요경영사항(OLP-1002 비마약성진통제 신약 영국 임상1상 시험결과)
Regulatory Filings
2021-03-29 Korean
권리락(무상증자)
Share Issue/Capital Change
2021-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-03-19 Korean
사업보고서 (2020.12)
Audit Report / Information FY 2020
2021-03-17 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2021-03-15 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change
2021-03-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-10 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-10 Korean
주주총회소집공고
AGM Information
2021-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-09 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-03-08 Korean
투자판단관련주요경영사항(OLP-1002 비마약성진통제 신약 호주 임상1b상 시험 진행 현황)
Regulatory Filings
2021-03-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-03-05 Korean
주주총회소집결의
AGM Information
2021-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-05 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2021-02-26 Korean
신주인수권행사
Share Issue/Capital Change
2021-02-04 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change
2021-02-02 Korean
전환청구권행사(제9회차 CB)
Share Issue/Capital Change
2021-02-01 Korean
기타경영사항(특허권취득)(자율공시)(Exon Skipping by Peptide Nucleic Acid Derivatives)
Regulatory Filings
2021-01-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-01-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-01-18 Korean